Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
Guillaume Cartron, Roch Houot, Yassine Al Tabaa, Fabien Le Bras, Loïc Ysebaert, Sylvain Choquet, Fabrice Jardin, Jacques‐Olivier Bay, François‐Xavier Gros, Franck Morschhauser, Olivier Casasnovas, Thomas Gastinne, Catherine Thiéblemont, Magalie Joris, Laure Ricard, Caroline Régny, Laurianne Drieu La Rochelle, Pierre Feugier, Ambroise Marçais, Samuel Griolet, Karin Tarte, Camille Laurent, Pierre Sesques
Topics & Concepts
Refractory (planetary science)Diffuse large B-cell lymphomaLymphomaMedicinePhase (matter)OncologyCancer researchInternal medicineMaterials scienceChemistryComposite materialOrganic chemistryCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers